Covid-19: Bahrain grants emergency use for Pfizer, BioNTech vaccine
The island kingdom of Bahrain says it has become the second nation in the world to grant an emergency-use authorization for the coronavirus vaccine made by Pfizer and its German partner BioNTech
AP Dubai The island kingdom of Bahrain says it has become the second nation in the world to grant an emergency-use authorization for the coronavirus vaccine made by Pfizer and its German partner BioNTech.
The state-run Bahrain News Agency made the announcement on Friday night.
It said it followed thorough analysis and review of all available data. Bahrain had already granted an emergency-use authorization for a Chinese vaccine made by Sinopharm.
Bahrain, home to the U.S. Navy's 5th Fleet, is a small island off the coast of Saudi Arabia in the Persian Gulf.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)